Suchergebnisse - "Bogos, Krisztina"

PubPharm (5)

1

Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer : an international multicenter study

enthalten in: The Journal of pathology | 2022

von Megyesfalvi, Z. | Barany, N. | Lantos, A. | +31

2

Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : updated results from a randomised, controlled, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Goldman, J. | Dvorkin, M. | Chen, Y. | +123

CommentIn: Lancet Oncol. 2021 Mar;22(3):e83. - PMID 33662291

3

Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience

enthalten in: Radiology and oncology | 2020

von Zemanova, M. | Pirker, R. | Petruzelka, L. | +23

4

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Paz-Ares, L. | Dvorkin, M. | Chen, Y. | +122

CommentIn: Lancet. 2019 Nov 23;394(10212):1884-1885. - PMID 31590987

5

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8) : an open-label randomised controlled phase 3 trial

enthalten in: The Lancet. Oncology | 2015

von Soria, J. | Felip, E. | Cobo, M. | +116

CommentIn: Lancet Oncol. 2015 Aug;16(8):872-3. - PMID 26156654

1
[1]